Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ML 171, Tocris Bioscience™

Catalog Number 465350
Click to view available options
Quantity:
50 mg
This item is not returnable. View return policy
6631-94-3
C14H11NOS
241.308
JWGBOHJGWOPYCL-UHFFFAOYSA-N
2-acetylphenothiazine, 1-10h-phenothiazin-2-yl ethanone, ethanone, 1-10h-phenothiazin-2-yl, methyl phenothiazin-2-yl ketone, 2-acetyl-10h-phenothiazine, 1-10h-phenothiazin-2-yl ethan-1-one, 3-acetylphenothiazine, 2-acetyl phenothiazine, bidd:gt0700
81131
1-(10H-phenothiazin-2-yl)ethanone
CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2
This item is not returnable. View return policy
6631-94-3
C14H11NOS
241.308
JWGBOHJGWOPYCL-UHFFFAOYSA-N
2-acetylphenothiazine, 1-10h-phenothiazin-2-yl ethanone, ethanone, 1-10h-phenothiazin-2-yl, methyl phenothiazin-2-yl ketone, 2-acetyl-10h-phenothiazine, 1-10h-phenothiazin-2-yl ethan-1-one, 3-acetylphenothiazine, 2-acetyl phenothiazine, bidd:gt0700
81131
1-(10H-phenothiazin-2-yl)ethanone
CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2

Selective NADPH oxidase 1 (NOX1) inhibitor

NADPH oxidase 1 (NOX1) inhibitor; blocks NOX1-dependent ROS generation (IC50 = 0.25 μM in a HEK293-NOX1 recombinant cell system). Selective for NOX1 over other NADPH oxidases (IC50 values are > 3 μM). Inhibits SrcYF-induced invadopodia formation in human DLD1 colon cancer cells.
Quantity 50 mg
Formula Weight 241.31
Percent Purity >98%
Chemical Name or Material ML 171
Recommended Storage Store at +4°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit